Summary
This 8-K filing from CVS Health, dated August 7, 2019, primarily announces a realignment of its business segments to better align with its operating model and how management reviews performance, effective for the first quarter of 2019. This includes moving the SilverScript Medicare Part D business from Pharmacy Services to Health Care Benefits, and Aetna's mail order and specialty pharmacy operations from Health Care Benefits to Pharmacy Services. Past financial information has been recast to reflect these changes, ensuring consistency in reporting and comparability for investors. The filing also includes an unaudited pro forma condensed combined statement of operations for CVS Health and Aetna for the year ended December 31, 2018, providing a clearer picture of the combined entity's financial performance prior to the reporting of actual combined results. This segment realignment is a significant operational update that impacts how investors should analyze the performance of CVS Health's distinct business units. The recasting of prior period data is crucial for understanding trends and evaluating the company's strategic execution, particularly following the Aetna acquisition. Investors should review the updated segment disclosures to gain a more accurate perspective on the profitability and contributions of each business area under the new structure. The pro forma statement is also important for understanding the historical financial profile of the merged entity.
Key Highlights
- 1CVS Health realigned its business segments for the first quarter of 2019 to reflect operational changes and management's review process.
- 2The SilverScript Medicare Part D prescription drug plan has been moved from the Pharmacy Services segment to the Health Care Benefits segment.
- 3Aetna's mail order and specialty pharmacy operations have been transferred from the Health Care Benefits segment to the Pharmacy Services segment.
- 4Prior period financial information has been restated (recast) to conform to the new segment reporting structure, enhancing comparability.
- 5The company is filing updated exhibits to its 2018 Annual Report on Form 10-K to reflect these segment changes retrospectively.
- 6An unaudited pro forma condensed combined statement of operations for CVS Health and Aetna for the year ended December 31, 2018, is included.
- 7This filing supersedes certain information in the company's 2018 Form 10-K related to business segments, management's discussion, and financial statements.